-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on GeneDx Holdings, Raises Price Target to $74

Benzinga·06/29/2026 14:07:19
Listen to the news
Guggenheim analyst Subbu Nambi maintains GeneDx Holdings (NASDAQ:WGS) with a Buy and raises the price target from $70 to $74.